Niconex Medical joins EuropaBio: Driving Regulatory Insight Within European Biotech
PRESS RELEASE
Brussels, 13 March 2026 – EuropaBio is pleased to welcome its newest member, Niconex Medical.
Founded in 2017 and based in Cyprus, Niconex Medical operates through two core pillars: Regulatory & Vigilance and Research & Innovation. Through its Regulatory & Vigilance services, the company provides local Regulatory Affairs and Pharmacovigilance support for Human Medicines and Biocidal products, both for products already on the market and for those seeking entry to the Cypriot market.
Under its Research & Innovation pillar, Niconex offers project coordination, regulatory and patentability research, as well as exploitation, dissemination and communication activities tailored to specific project needs. With a strong focus on Life Sciences and Health Biotechnology, Niconex’s work aligns closely with EuropaBio’s priorities and advocacy efforts across the EU biotechnology landscape.
By joining EuropaBio, Niconex aims to remain at the forefront of legislative and regulatory developments, strengthening support for its clients and contributing to policy conversations that shape the future of the European biotech sector. The company is committed to sharing evidence and expertise from its regulatory and research activities, while also representing the perspectives and frameworks of smaller Member States such as Cyprus.
Dr Claire Skentelbery, Director General of EuropaBio, commented: “It is excellent to welcome Nicolas and Niconex Medical into EuropaBio. Sector and regulatory expertise in healthcare are at the core of our strength, and we look forward to a impactful 2026 together.”
Dr Nicolas Constantinou, Director at Niconex Medical, said: “The opportunity to be a part of EuropaBio is invaluable, especially as a small consultancy; it is with sincere gratitude and pleasure to be involved along with esteemed peers at the frontier of European biotech ecosystem, and in parallel, pave a way forward that remains adhered to Niconex core values of integrity, transparency, urgency and quality.”
For more information, please visit niconex.eu



